Psychometric evaluation of the Nocturia Sleep Quality Scale based on data from a prospective observational study.

Nocturia Sleep Quality Scale (NSQS) nocturia psychometric analyses reliability sleep impacts validity

Journal

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
ISSN: 1550-9397
Titre abrégé: J Clin Sleep Med
Pays: United States
ID NLM: 101231977

Informations de publication

Date de publication:
01 04 2021
Historique:
pubmed: 19 11 2020
medline: 30 6 2021
entrez: 18 11 2020
Statut: ppublish

Résumé

The Nocturia Sleep Quality Scale (NSQS), a novel patient-reported outcomes measure, was developed to assess the impact of sleep disturbance from nocturia. The objective of this study was to assess the psychometric properties of the NSQS, including its structure, reliability, and validity. Data were collected in the context of a web-based, prospective, longitudinal, observational study. Participants with nocturia were randomized 1:1 to either a group that received sleep hygiene instructions, including instructions to limit liquids at nighttime and empty bladder prior to bedtime, or one that did not receive sleep instructions. All participants were asked to provide responses to the web-based questionnaires from day 1 to day 10. Psychometric analyses, aligned with current regulatory guidance, were conducted to evaluate the daily scores and 3-day average scores of NSQS items and potential composites. Item-level analyses were conducted first, followed by composite-level analyses. The NSQS items and supporting measures demonstrated very slight improvement in patient-perceived sleep disturbance from nocturia over the course of the study. NSQS test-retest reliabilities were generally satisfactory. Correlations between NSQS items and related patient-reported measures tended to support the construct validity of the NSQS, and the known-groups analyses supplied evidence of its discriminating ability. NSQS responsiveness statistics were small. The NSQS is a reliable and valid measure of the impact of nocturia on patients' sleep. The present analyses lay the psychometric groundwork for the use of the NSQS in future clinical trials to support product approval and labeling claims.

Identifiants

pubmed: 33206043
doi: 10.5664/jcsm.9010
pmc: PMC8020686
doi:

Types de publication

Journal Article Observational Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

691-701

Informations de copyright

© 2021 American Academy of Sleep Medicine.

Références

Urology. 2019 Nov;133S:24-33
pubmed: 31586470
J Sleep Res. 2003 Mar;12(1):1-12
pubmed: 12603781
J Clin Sleep Med. 2007 Aug 15;3(5):519-28
pubmed: 17803017
Sleep. 2003 Mar 15;26(2):117-26
pubmed: 12683469
Ther Innov Regul Sci. 2015 Nov;49(6):805-812
pubmed: 30222389
Am J Obstet Gynecol. 2003 Oct;189(4):1106-13
pubmed: 14586363
BJU Int. 2005 Nov;96(7):1049-54
pubmed: 16225527
Sleep Med. 2009 May;10(5):540-8
pubmed: 18703381
Int J Clin Pract. 2018 Jun;72(6):e13091
pubmed: 29767479
J Urol. 2017 Feb;197(2S):S189-S197
pubmed: 28012747
Int J Clin Pract. 2017 Nov;71(11):
pubmed: 28984060
Neurourol Urodyn. 2019 Feb;38(2):478-498
pubmed: 30779378
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Sleep Med Rev. 2011 Apr;15(2):91-7
pubmed: 20965130
J Clin Epidemiol. 2008 Feb;61(2):102-9
pubmed: 18177782
Value Health. 2014 Sep;17(6):696-706
pubmed: 25236993
Neurourol Urodyn. 2002;21(2):179-83
pubmed: 11857672
Eur Urol. 2010 Mar;57(3):488-96
pubmed: 19361907
Sleep Med. 2019 Jul;59:101-106
pubmed: 31072693
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Eur Urol. 2006 Apr;49(4):710-9
pubmed: 16442700
Int J Clin Pract. 2019 Aug 27;:e13408
pubmed: 31456335
Qual Life Res. 2003 Jun;12(4):349-62
pubmed: 12797708
Eur J Health Econ. 2017 Jul;18(6):761-771
pubmed: 27678109
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683

Auteurs

Valerie Williams (V)

RTI Health Solutions, Research Triangle Park, North Carolina.

Shanshan Qin (S)

RTI Health Solutions, Research Triangle Park, North Carolina.

Carla DeMuro Romano (CD)

RTI Health Solutions, Research Triangle Park, North Carolina.

Sandy Lewis (S)

RTI Health Solutions, Research Triangle Park, North Carolina.

Nicole Williams (N)

RTI Health Solutions, Research Triangle Park, North Carolina.

Stuart Yarr (S)

RTI Health Solutions, Research Triangle Park, North Carolina.

Kristian V Juul (KV)

Ferring Pharmaceuticals A/S, Copenhagen, Denmark.

Fredrik L Andersson (FL)

Ferring Pharmaceuticals A/S, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH